Conference themes
During clinical trials, inspections provide a framework to ensure quality and integrity of care, data and drug performance. As sponsors of clinical trials, it is important for pharmaceutical companies to ensure GCP guidelines are upheld by implementing inspection readiness. These inspections, often conducted by the FDA, EMA, MHRA and other regulatory authorities, all have unique regulations and caveats.
Professional congress organizer (PCO)
ExL Events
Notes
Brochure: https://go.evvnt.com/203143-1?pid=4832
Speakers: Kath Williams, Lindsay Watt, Geoff Taylor, Winnie Sojborg Sussoh, Patricia (Moore) Pengelly, Nicola Parr, Fareha Nagi, Anna Szaff Lundsgaard, Dr. Christian Langeluddecke, and more.
Enquiries and Registration:
https://go.evvnt.com/203143-2?pid=4832
Ms. Camille Venturina
CategoriesGeneral Medicine